SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000930413-09-001405
Filing Date
2009-03-13
Accepted
2009-03-12 21:17:19
Documents
6
Period of Report
2009-03-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 c56940_8k.htm 8-K 21624
2 c56940_ex2-1.htm EX-2.1 366881
3 c56940_ex99-1.htm EX-99.1 8932
4 GRAPHIC c56940_ex99-1x1x1.jpg GRAPHIC 8083
5 c56940_ex99-2.htm EX-99.2 31644
6 GRAPHIC c56940_ex99-2x1x1.jpg GRAPHIC 8037
  Complete submission text file 0000930413-09-001405.txt   453294
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

IRS No.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 001-09974 | Film No.: 09677180
SIC: 8071 Services-Medical Laboratories